13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen

被引:43
作者
Jones, JG
Solomon, MA
Sherry, AD
Jeffrey, FMH
Malloy, CR
机构
[1] Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75216 USA
[3] Dept Vet Affairs Med Ctr, Dallas, TX 75216 USA
[4] Univ Dallas, Dept Chem, Richardson, TX 75083 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1998年 / 275卷 / 05期
关键词
glucose; glucuronide; glutamine; isotopomers; nuclear magnetic resonance;
D O I
10.1152/ajpendo.1998.275.5.E843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anaplerotic, pyruvate recycling, and gluconeogenic fluxes were measured by C-13 isotopomer analysis of plasma glucose, urinary phenylacetylglutamine, and urinary glucuronide in normal, 24-h-fasted individuals after ingestion of [U-C-13]propionate, phenylacetate, and acetaminophen. Plasma glucose isotopomer analysis reported a total anaplerotic flux of 5.92 +/- 1.03 (SD) relative to citrate synthase. This was not significantly different from glucuronide and phenylacetylglutamine analyses (6.08 +/- 1.16 and 7.14 +/- 1.94, respectively). Estimates of pyruvate recycling from glucose and glucuronide isotopomer distributions were almost identical(3.55 +/- 0.99 and 3.66 +/-: 1.11, respectively), whereas phenylacetylglutamine reported a significantly higher estimate (5.74 +/- 2.13). As a consequence, net gluconeogenic flux reported by phenylacetylglutamine (1.41 +/- 0.28) was significantly less than that reported by glucose (2.37 +/- 0.64) and glucuronide (2.42 +/-: 0.76). This difference in fluxes detected by analysis of phenylacetylglutamine vs. hexose is likely due to compartmentation of hepatic metabolism of propionate. Net gluconeogenic flux estimates made by use of this stable isotope method are in good agreement with recent measurements in humans with [C-14]propionate.
引用
收藏
页码:E843 / E852
页数:10
相关论文
共 41 条
[1]   3-HYDROXYPROPIONATE - SIGNIFICANCE OF BETA-OXIDATION OF PROPIONATE IN PATIENTS WITH PROPIONIC ACIDEMIA AND METHYLMALONIC ACIDEMIA [J].
ANDO, T ;
RASMUSSEN, K ;
HULL, D ;
NYHAN, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (10) :2807-+
[3]   TRACING HEPATIC GLUCONEOGENESIS RELATIVE TO CITRIC-ACID CYCLE ACTIVITY IN-VITRO AND IN-VIVO - COMPARISONS IN THE USE OF [3-C-13]LACTATE, [2-C-13]ACETATE, AND ALPHA-KETO[3-C-13]ISOCAPROATE [J].
BEYLOT, M ;
SOLOVIEV, MV ;
DAVID, F ;
LANDAU, BR ;
BRUNENGRABER, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1509-1514
[4]  
BLAIR JB, 1973, J BIOL CHEM, V248, P3608
[5]   INTERACTION OF CARNITINE AND PROPIONATE WITH PYRUVATE OXIDATION BY HEPATOCYTES FROM CLOFIBRATE-TREATED RATS - IMPORTANCE OF COENZYME-A AVAILABILITY [J].
BRASS, EP .
JOURNAL OF NUTRITION, 1992, 122 (02) :234-240
[6]   EFFECT OF PROPIONATE ON METABOLISM OF PYRUVATE AND LACTATE IN PERFUSED RAT-LIVER [J].
CHAN, TM ;
FREEDLAND, RA .
BIOCHEMICAL JOURNAL, 1972, 127 (03) :539-+
[7]   Quantifying gluconeogenesis during fasting [J].
Chandramouli, V ;
Ekberg, K ;
Schumann, WC ;
Kalhan, SC ;
Wahren, J ;
Landau, BR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06) :E1209-E1215
[8]   C-13-NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY STUDIES OF HEPATIC GLUCOSE-METABOLISM IN NORMAL SUBJECTS AND SUBJECTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CLINE, GW ;
ROTHMAN, DL ;
MAGNUSSON, I ;
KATZ, LD ;
SHULMAN, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2369-2376
[9]   SHORT CHAIN FATTY-ACIDS IN HUMAN LARGE-INTESTINE, PORTAL, HEPATIC AND VENOUS-BLOOD [J].
CUMMINGS, JH ;
POMARE, EW ;
BRANCH, WJ ;
NAYLOR, CPE ;
MACFARLANE, GT .
GUT, 1987, 28 (10) :1221-1227
[10]   VOLATILE FATTY-ACIDS IN HUMAN PERIPHERAL AND PORTAL BLOOD - QUANTITATIVE-DETERMINATION BY VACUUM DISTILLATION AND GAS-CHROMATOGRAPHY [J].
DANKERT, J ;
ZIJLSTRA, JB ;
WOLTHERS, BG .
CLINICA CHIMICA ACTA, 1981, 110 (2-3) :301-307